Foley Knows Life Sciences
For over a quarter of a century, Foley has provided comprehensive legal services for innovative enterprises in the pharmaceutical, biotechnology, biomedical, and health care sectors. The cornerstone of our success has been our unique ability to blend technical and legal insights with an understanding of our clients' real-world business needs.
By melding crucial legal disciplines within Foley, our Life Sciences Industry Team meets the diverse requirements of life science enterprises — from accessing private equity and managing intellectual property (IP) to securing regulatory approval and addressing the challenges of corporate compliance. Our experience, knowledge, and integration means that we afford our clients long-range strategies, not just short term solutions… and that equals smarter business practices overall.
Our attorneys know the life sciences because that's where they live. Members of Foley's Life Sciences Industry Team have research or commercial experience in the field, and many hold Ph.D.s in a relevant science. We have offices where you are, too — from the biotech hot bed of Boston and cutting-edge California to the surging markets in Shanghai and key cities in between, Foley is ingrained in the thriving life science communities that we represent.
Foley also supports and participates in numerous industry conferences throughout the year.
Foley provides assistance in all areas of the business life cycle. From start-up and patents to regulatory and initial public offering (IPO) issues, our integrated Life Sciences Industry Team can suggest strategies that will keep your company on the path to success.
Funding
Potential venture partners and would-be investors alike must learn all that they can about the IP position of a life science company and the chances for its achieving regulatory approval. On these crucial issues, Foley's Life Sciences Industry Team offers a unified perspective for both the life sciences sectors and their sources of funding.
We understand the distinctive needs and objectives of private equity and venture capital funds. We have represented venture investors and buyout groups for nearly half a century. With a team of over 200 attorneys focusing on the full range of public and private debt and equity vehicles and their investment activities, we bring a sophisticated and efficient approach to structuring funds and their investments. Our comprehensive understanding of the market, trends, and issues positions us as integral members of our clients' teams, working collaboratively to achieve their objectives.
We create the appropriate vehicles for private equity funds, fund-of-funds, angel funds, early and late stage venture capital funds, mezzanine funds, hedge funds, turnaround and distressed debt funds, and employee co-investment funds, among others. We are capable of meeting our clients' needs, whether they involve venture capital investments ranging from seed to later round and mezzanine stages; controlling equity investments in public and private companies; PIPE investments; buyout transactions; or IPOs.
